MVP to provide AstraZeneca COVID-19 vaccines for PBA | Inquirer Sports

MVP to provide AstraZeneca COVID-19 vaccines for PBA

By: - Reporter / @MarkGiongcoINQ
/ 04:12 PM March 10, 2021

Manny V Pangilinan MVP

FILE – Manny V. Pangilinan. Photo by Tristan Tamayo/

MANILA, Philippines — Sports patron Manny V. Pangilinan will be providing vaccines for the PBA in time for its 46th season.

Pangilinan, the business tycoon who owns three PBA franchises in Talk ’N Text, Meralco and NLEX, is expected to donate 3,000 doses of AstraZeneca COVID-19 vaccines for 1,500 members of the PBA family.


“We are very grateful to MVP for really looking after the welfare of the players of all teams and their dependents,” said PBA board vice chair Bobby Rosales in a press conference Tuesday.


“So anytime that those vaccines arrive this will be offered and given to the players and their dependents.”

A total of 487,200 doses of the vaccine, developed by the British-Swede pharmaceutical firm, arrived in the Philippines on Thursday while an additional 38,400 doses followed.

The AstraZeneca jabs were from the World Health Organisation-led COVAX facility, which promised 525,600 doses to the Philippines.

The PBA is tentatively set to begin its 46th season on April 11.


MVP group willing to allocate COVID-19 vaccines to UAAP

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Manny V. Pangilinan, MVP, pandemic, PBA, vaccines

© Copyright 1997-2024 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.